Glutamate receptors in extinction and extinction-based therapies for psychiatric illness - Test2 - elhamkhani - TriplyDB

Glutamate receptors in extinction and extinction-based therapies for psychiatric illness

Glutamate receptors in extinction and extinction-based therapies for psychiatric illness

http://www.wikidata.org/entity/Q30477927

about

NMDA receptors and fear extinction: implications for cognitive behavioral therapy Pharmacological treatment of PTSD - established and new approaches Role of cues and contexts on drug-seeking behaviour Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress Extinction of conditioned opiate withdrawal in rats in a two-chambered place conditioning apparatus.The Regulation of Cytokine Networks in Hippocampal CA1 Differentiates Extinction from Those Required for the Maintenance of Contextual Fear Memory after Recall Rethinking Extinction Fear extinction as a model for translational neuroscience: ten years of progress.D-cycloserine effects on extinction of conditioned responses to drug-related cues The Plasticity of Extinction: Contribution of the Prefrontal Cortex in Treating Addiction through Inhibitory Learning Psychological and neural mechanisms of experimental extinction: a selective review Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.Pharmacological enhancement of fear reduction: preclinical models.Deep brain stimulation of the ventral striatum enhances extinction of conditioned fear.Testing the effects of Δ9-THC and D-cycloserine on extinction of conditioned fear in humans.Glycine transporter-1 inhibition preceding extinction training inhibits reacquisition of cocaine seeking Analysis of the rat hypothalamus proteome by data-independent label-free LC-MS/MS.Memory acquisition and retrieval impact different epigenetic processes that regulate gene expression.Extinction and renewal of conditioned sexual responses.The overlap between binge eating disorder and substance use disorders: Diagnosis and neurobiology.Cognitive enhancers in the treatment of substance use disorders: clinical evidence.Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments.HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand?Bidirectional effects of inhibiting or potentiating NMDA receptors on extinction after cocaine self-administration in rats mGluR5 positive allosteric modulation enhances extinction learning following cocaine self-administration.Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal.Dorsal hippocampal NMDA receptor blockade impairs extinction of naloxone-precipitated conditioned place aversion in acute morphine-treated rats by suppressing ERK and CREB phosphorylation in the basolateral amygdala.Is an epigenetic switch the key to persistent extinction?New medications for drug addiction hiding in glutamatergic neuroplasticity.Extinction of conditioned opiate withdrawal in rats is blocked by intracerebroventricular infusion of an NMDA receptor antagonist.Translating glutamate: from pathophysiology to treatment.The mGluR5 Positive Allosteric Modulator CDPPB Does Not Alter Extinction or Contextual Reinstatement of Methamphetamine-Seeking Behavior in Rats Glutamate modulators in the treatment of obsessive-compulsive disorder.Fear extinction and BDNF: translating animal models of PTSD to the clinic.Altered acquisition and extinction of amphetamine-paired context conditioning in genetic mouse models of altered NMDA receptor function.From antipsychotic to anti-schizophrenia drugs: role of animal models.Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model.Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use.Role of medial prefrontal cortex Narp in the extinction of morphine conditioned place preference.

P2860

Q24604822-2FE3B9BE-C3F0-4D6B-BBB6-A0E69AAD5A54 Q24633256-3AF35EFB-7041-4AA4-85F8-68B7696C4E59 Q26825476-D94BFABB-1CD7-4BF1-B50D-F256175945E1 Q27006437-001CC2EA-E14F-4B45-8117-4149CE2FA0D0 Q27022219-DBD309AF-A4C0-4F60-BDE2-96A938030DBF Q27310390-5103C703-54E9-4B68-BE1B-C6CCBDCF4E81 Q27314764-3A9D5791-B145-43C8-8AF7-9AA785DB5161 Q28084425-D0CA1BD8-8946-4A61-AC5E-EE9F744AA7F3 Q28254365-3A4B77CB-4CEA-4BBD-AFB9-5CB626122E10 Q28266461-54BD7E17-39FC-4165-AE2A-2EE43CE4866B Q28685095-7E2F576F-C59E-49C3-B194-E134D1F4B3AD Q30419931-B2BD7A00-D99C-49AA-983B-C8180C5A1DDD Q30442231-3C57EC53-ED4B-4D0C-BAAE-A19CF56EE84A Q30462825-7B26F2D8-1CB4-4883-83F2-F55A70BAA62E Q30514335-F34EE5B1-4A43-4CA3-9E92-91B7F5D82F33 Q30525198-2AEBF8B3-C8D3-4497-86AF-E6C644329392 Q30528438-E9D6E4B4-C310-4086-A2A6-0DC19917A01B Q30569671-1E01EDA4-4CDD-46B7-8606-29C76A722309 Q30653843-33DEA918-9241-414C-B259-B904CD9F4EA8 Q34110272-D9D3DF0C-8E0C-46D4-9BAC-8C33BF36D314 Q34133292-4A0102D4-F1D1-4332-BE4B-67765B301CF5 Q34183988-7E48A91A-2E37-4D98-91C9-681B70F17AC0 Q34224871-F21C33E0-262A-4E49-9DD6-711F938A161F Q34410902-5F66509F-E02F-4F9E-B962-CA48C06FE955 Q34517093-DE738DEC-12F5-4E50-9504-D07B94E40963 Q34775016-41FF3D8B-1695-479C-92F8-7887E668DA8D Q34870758-E865C54D-F3E7-443B-A53D-73521408DE51 Q34939756-7AFD85DE-23D9-4947-8357-DF1BC8F0403F Q35036750-7675C355-13CE-47ED-9493-BC8E6100361A Q35333393-A84FE435-E6CA-46E2-AC73-CE0145985A3E Q35671087-DA962240-165F-4A29-89D0-98D43ABD2E39 Q35739457-07B92A53-5C04-45F5-A7AB-4B7774488F17 Q35833718-4BFF9BDC-8E19-4892-8D96-2A575824752A Q35897264-3DCC058E-F174-4568-81AC-87C79942009A Q36074354-72F552F1-02F2-459B-9CB9-37C5238EFE12 Q36234265-7D4E3796-A44B-4722-88FC-90BF8C5779C9 Q36287726-445F1D5C-8982-4152-A774-75EF26E0D5EE Q36328780-8604339D-F87B-445F-9710-B278EA6BA08E Q36540742-161E8F97-B67F-4FCC-AA07-622B443F53B3 Q36545380-B73909CC-4072-4ED3-9545-621A332B5241

P2860

Glutamate receptors in extinction and extinction-based therapies for psychiatric illness

http://www.wikidata.org/entity/Q30477927

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Glutamate receptors in extinction and extinction-based therapies for psychiatric illness

@ast

Glutamate receptors in extinction and extinction-based therapies for psychiatric illness

@en

type

label

Glutamate receptors in extinction and extinction-based therapies for psychiatric illness

@ast

Glutamate receptors in extinction and extinction-based therapies for psychiatric illness

@en

prefLabel

Glutamate receptors in extinction and extinction-based therapies for psychiatric illness

@ast

Glutamate receptors in extinction and extinction-based therapies for psychiatric illness

@en

P1433

Q30477927-F217FDF0-EF0D-4D87-8FB9-F9C21181EA32

P1476

Q30477927-C371E304-F292-4513-BEC9-7CC9017521A9

P2093

Q30477927-742788C8-1771-48C5-B2DA-FDE64EB69257

Q30477927-92724FE5-4E20-4B4B-B787-099E9A49EC2D

Q30477927-EB55B913-B8AF-4709-A047-E6451026B8AB

P2860

Q30477927-031DD603-A5CE-4BD2-B592-5B1CEC83ED4B

Q30477927-0381EDCD-B70C-478E-9C6C-BB328409AA58

Q30477927-0391AFA2-3B9F-4479-BB76-1B6B8A5FF0C7

Q30477927-039CE84E-C912-40F6-A0FF-2FF895B0CFFC

Q30477927-0440E05A-C64F-432F-B265-A020F9C11F54

Q30477927-04518DA7-59DF-48AC-98F5-35D0773AE000

Q30477927-04A1899E-3D51-4FD5-820C-0385F43DB366

Q30477927-077FD04A-8B25-4AC2-97A6-45774FB6168E

Q30477927-09ED09C6-40C7-480D-87B1-F6381C48E149

Q30477927-0DDC87CF-E47C-4EEF-AE3A-D328A3D18D1F

P2888

Q30477927-C153DA2A-F158-4828-8445-2307740B47F2

P304

Q30477927-B2A420A8-D312-49E1-A7E1-D8C01D7C5CA8

P31

Q30477927-31838B91-B0EA-4991-88BB-FB3D965B1192

P356

Q30477927-67AAAD01-4CB1-4CC1-A3EC-347727FF9782

P407

Q30477927-3ADA0E6A-8AAB-487A-AAB7-0350120C970A

P433

Q30477927-49239E6D-E830-43D6-97FC-FB0E6BB27EB9

P478

Q30477927-BBF6786C-F371-4263-86E5-87B57A19A04C

P577

Q30477927-55854663-F84A-4FE6-B0BA-F2236555EF48

P6179

Q30477927-89446F29-6CA0-49DC-A360-E951D68AA2C7

P698

Q30477927-4A139371-7FF0-4283-83B8-718A47ABFE6E

P932

Q30477927-C97F8DB1-5EB7-4942-BF6F-FAEBF2986C28

P356

P1433

Neuropsychopharmacology

P1476

Glutamate receptors in extinction and extinction-based therapies for psychiatric illness

@en

P2093

Karyn M Myers

http://www.w3.org/2001/XMLSchema#string

Michael Davis

http://www.w3.org/2001/XMLSchema#string

William A Carlezon

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic enhancement of learning and memory in mice

Positive allosteric modulation of mGluR5 receptors facilitates extinction of a cocaine contextual memory

D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning

The role of ventromedial prefrontal cortex in the recovery of extinguished fear

Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval

Extinction circuits for fear and addiction overlap in prefrontal cortex

Concomitant deficits in working memory and fear extinction are functionally dissociated from reduced anxiety in metabotropic glutamate receptor 7-deficient mice

Prefrontal dopamine D4 receptors are involved in encoding fear extinction

Place navigation impaired in rats with hippocampal lesions

AMPA receptor trafficking and synaptic plasticity

P2888

P304

274-293

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2010.88

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010283974

http://www.w3.org/2001/XMLSchema#string

P698

20631689

http://www.w3.org/2001/XMLSchema#string

P932

2994960

http://www.w3.org/2001/XMLSchema#string